The Royal Australian and New Zealand College of Ophthalmologists (RANZCO) is hosting a one-day virtual event on 10 September 2022, highlighting what practitioners can expect from the next five years of advances in ophthalmology.
Dr Nicholas Jones has joined Health New Zealand as its new director of public health, succeeding Dr Caroline McElnay, who resigned in April 2022 after holding the role for nearly six years.
A US study has shown a revised dietary supplement, with antioxidants lutein and zeaxanthin replacing beta-carotene, reduces the cancer risks associated with the previous formula and is more effective
A German study has shown the analgesic nalbuphine (Nubain) reduces the incidence of emergence delirium/agitation (EDA) in preschool children undergoing ophthalmic surgery. EDA is defined by Vlajkovic
An Auckland University team that developed a tool to reduce bullying on clinical placements has won an Impac-sponsored Safeguard New Zealand Workplace Health and Safety Award.
Two separate US studies found diabetic retinopathy (DR) diagnosis and grading were more accurate and consistent using ultra-wide field (UWF) fluorescein angiography (FA) compared to UWF colour fundus
Prototype spectacles using 3D cameras, microwaves and artificial intelligence to detect explosives and firearms in public spaces have completed a month of testing in a Rome subway station.
Glaukos has received the US Food and Drug Administration (FDA) premarket approval for its iStent infinite trabecular micro-bypass system to reduce intraocular pressure (IOP) in patients with primary
Australian brand AM Eyewear said it has been overwhelmed with requests from all over the world to re-release a pair of limited-edition sunnies sported by actor Johnny Depp during his defamation trial with ex-wife Amber Heard. The style, Ava in Mellow Yellow, is appearing online at inflated prices, w
A dermatologist in a Saudi Arabian clinic has successfully treated a case of eyelid ptosis attributed to cosmetic Botox injection with brimonidine 0.33% gel (Mirvaso Gel).
An international team has developed a self-plugging, drug-tipped microneedle to reduce the inflammation risks and guard against other possible complications of repeated intravitreal injections.
The size of the primary visual cortex and the amount of brain tissue dedicated to processing visual information can indicate the quality of an individual’s contrast sensitivity, according to neuroscientists at New York University.
